Therefore, further studies to identify the molecular mechanisms of action of Lonp1 in different cell types/tissues in obesity/MetS and its role in regulating mtDNA will provide new perspectives and a basis for developing effective prognostic and therapeutic pathogenesis-based strategies for the treatment of metabolic diseases. This evidence concerns the gene LONP1 and obesity due to melanocortin 4 receptor deficiency.